Downregulation of MHC-I as an immune escape mechanism in melanoma

被引：0

作者：

Braun, A. D. ^{[1
]}

Mengoni, M. ^{[1
]}

Rambow, F. ^{[2
]}

Marine, J. C. ^{[3
]}

Tueting, T. ^{[1
]}

机构：

[1] Univ Klinikum Magdeburg, Magdeburg, Germany

[2] Univ Klinikum Essen, Dept Appl Computat Canc Res, Essen, Germany

[3] Ctr Canc Biol, Lab Mol Canc Biol, Leuven, Belgium

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

FV01

引用

页码：3 / 3

页数：1

共 50 条

[31] Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto
Anthony Venida
Julian Yano
Douglas E. Biancur
Miwako Kakiuchi
Suprit Gupta
Albert S. W. Sohn
Subhadip Mukhopadhyay
Elaine Y. Lin
Seth J. Parker
Robert S. Banh
Joao A. Paulo
Kwun Wah Wen
Jayanta Debnath
Grace E. Kim
Joseph D. Mancias
Douglas T. Fearon
Rushika M. Perera
Alec C. Kimmelman
Nature, 2020, 581 : 100 - 105
[32] Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types
Muntjewerff, Elke M.
Meesters, Luca D.
van den Bogaart, Geert
Revelo, Natalia H.
FRONTIERS IN IMMUNOLOGY, 2020, 11
[33] MHC class I antigens, immune surveillance, and tumor immune escape
Garcia-Lora, A
Algarra, I
Garrido, F
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (03) : 346 - 355
[34] MHC-I prediction using a combination of T cell epitopes and MHC-I binding peptides
Vider-Shalit, Tal
Louzoun, Yoram
JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 374 (1-2) : 43 - 46
[35] INCREASING MHC-I EXPRESSION TO POTENTIATE IMMUNE CHECKPOINT BLOCKADE THERAPY
Gu, Shengqing
Zhang, Wubing
Wang, Xiaoqing
Jiang, Peng
Traugh, Nicole
Li, Ziyi
Meyer, Clifford
Stewig, Blair
Xie, Yingtian
Bu, Xia
Manos, Michael
Font-Tello, Alba
Gjini, Evisa
Lako, Ana
Lim, Klothilda
Conway, Jake
Tewari, Alok
Zeng, Zexian
Das Sahu, Avinash
Tokheim, Collin
Weirather, Jason
Fu, Jingxin
Zhang, Yi
Kroger, Benjamin
Liang, Jin Hua
Cejas, Paloma
Freeman, Gordon
Rodig, Scott
Long, Henry
Gewurz, Benjamin
Hodi, F. Stephen
Brown, Myles
Liu, X. Shirley
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A728 - A728
[36] Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
Gu, Shengqing Stan
Zhang, Wubing
Wang, Xiaoqing
Jiang, Peng
Traugh, Nicole
Li, Ziyi
Meyer, Clifford
Stewig, Blair
Xie, Yingtian
Bu, Xia
Manos, Michael P.
Font-Tello, Alba
Gjini, Evisa
Lako, Ana
Lim, Klothilda
Conway, Jake
Tewari, Alok K.
Zeng, Zexian
Das Sahu, Avinash
Tokheim, Collin
Weirather, Jason L.
Fu, Jingxin
Zhang, Yi
Kroger, Benjamin
Liang, Jin Hua
Cejas, Paloma
Freeman, Gordon J.
Rodig, Scott
Long, Henry W.
Gewurz, Benjamin E.
Hodi, F. Stephen
Brown, Myles
Liu, X. Shirley
CANCER DISCOVERY, 2021, 11 (06) : 1524 - 1541
[37] A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma
Capasso, Cristian
Magarkar, Aniket
Cervera-Carascon, Victor
Fusciello, Manlio
Feolaf, Sara
Muller, Martin
Garofalo, Mariangela
Kuryk, Lukasz
Tahtinen, Siri
Pastore, Lucio
Bunker, Alex
Cerullo, Vincenzo
ONCOIMMUNOLOGY, 2017, 6 (09):
[38] Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
Yu, Jing
Wu, Xi
Song, Jinen
Zhao, Yujie
Li, Huifang
Luo, Min
Liu, Xiaowei
FRONTIERS IN PHARMACOLOGY, 2022, 13
[39] Downregulation of MHC-I on Melanoma Cells and Decreased CD8+T-Cell Infiltration Are Associated With Metastatic Spread and Resistance to Immunotherapy
Mengoni, Miriam
Mahlo, Felix O.
Gaffal, Evelyn
Tueting, Thomas
Braun, Andreas D.
LABORATORY INVESTIGATION, 2025, 105 (03)
[40] Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Wu, Xiangyu
Li, Tianhang
Jiang, Rui
Yang, Xin
Guo, Hongqian
Yang, Rong
MOLECULAR CANCER, 2023, 22 (01)

← 1 2 3 4 5 →